THROMBIN-JMI

Product NDC
60793-333
11-digit product format
607930333
Labeler code
60793
Product ID
60793-333_3def28ab-84bb-4137-a4d8-450ef97c97cc
Type
PLASMA DERIVATIVE
Nonproprietary name
thrombin, topical (bovine)
Dosage form
LIQUID
Route
TOPICAL
Labeler
Pfizer Laboratories Div Pfizer Inc
Application
BLA102865
Marketing category
BLA
Marketing start
2026-08-31
Substance
THROMBIN
Active strength
5000 [iU]/5mL
Pharmacologic classes
Blood Coagulation Factor [EPC], Blood Coagulation Factors [CS], Increased Coagulation Factor Activity [PE]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
THROMBIN-JMI
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
THROMBIN5000 [iU]/5mL

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
102865Thrombin-Jmi, ThrombocollThrombin, Topical (Bovine)351(a)Rx2026-09-01

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
60793-333-01607930333011 VIAL, SINGLE-DOSE in 1 CARTON (60793-333-01) / 5 mL in 1 VIAL, SINGLE-DOSE (60793-333-05) 2026-08-31NoNoCurrent